Related Experiment Videos
Fewer symptoms occur in same-serotype recurrent streptococcal tonsillopharyngitis
L H Lee1, E Ayoub, M E Pichichero
1Food and Drug Administration, Division of Vaccines and Related Product Applications, HFM 475, Suite 370N, 1401 Rockville Pike, Rockville, MD 20852, USA.
Archives of Otolaryngology--Head & Neck Surgery
|November 14, 2000
Summary
Recurrent group A beta-hemolytic streptococcal (GABHS) tonsillopharyngitis often presents with fewer symptoms than initial infections. This can lead to delayed medical attention, increasing the risk of serious complications.
Area of Science:
- Infectious Diseases
- Microbiology
- Pediatrics
Background:
- Acute rheumatic fever diagnosis often lacks a clear history of antecedent pharyngitis.
- Recurrent group A beta-hemolytic streptococcal (GABHS) infections are a concern in tonsillopharyngitis management.
Purpose of the Study:
- To characterize the clinical and microbiological features of recurrent GABHS tonsillopharyngitis.
- To identify patterns distinguishing recurrent GABHS infections from initial episodes.
Main Methods:
- Prospective randomized trial design.
- Symptom recording and throat cultures at multiple time points post-treatment.
- Serological confirmation (antistreptolysin O, anti-deoxyribonuclease B titers) for bona fide recurrences in a subset of patients.
Main Results:
- 27% of patients experienced bona fide recurrent GABHS tonsillopharyngitis of the same serotype within 55 days.
- Recurrent infections showed significantly fewer symptoms (headache, sore throat, fever, pharyngeal erythema/edema, adenitis) compared to initial episodes.
- Certain symptoms like chills and stomachache were similar between initial and recurrent episodes.
Conclusions:
- Recurrent GABHS tonsillopharyngitis of the same serotype may present with milder symptoms.
- Reduced symptom severity might lead to decreased physician consultation, potentially increasing the risk of sequelae.
- Understanding these differences is crucial for effective management and prevention of complications.